Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by moonball32on Dec 30, 2021 10:14pm
127 Views
Post# 34272880

RE:Company Email

RE:Company EmailI sense the longs are quickly losing patience with the company. Missed promises, delays, some within the company's control, others not. When Biden is promising 500 million at home tests, having this company commit 2.5 million tests a month really doesn't seem too appealing for the FDA to push the approval through quickly even given the test is more user friendly than current swab tests. May be time to put stop losses in place to protect some capital. I hope I am wrong and the company thrives, just lots of doubts in the mix right now. Rob needs to start to walk the talk, if he isn't sure about a timeline, just don't wing it to try to please shareholders, investors want results not bs promises, he is at the crossroads, let's hope he can lead this company in the right direction.
<< Previous
Bullboard Posts
Next >>